Annual EBITDA
$129.34 M
-$153.96 M-54.35%
December 31, 2023
Summary
- As of February 7, 2025, CCRN annual EBITDA is $129.34 million, with the most recent change of -$153.96 million (-54.35%) on December 31, 2023.
- During the last 3 years, CCRN annual EBITDA has risen by +$126.10 million (+3902.94%).
- CCRN annual EBITDA is now -54.35% below its all-time high of $283.29 million, reached on December 31, 2022.
Performance
CCRN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$8.44 M
+$22.71 M+159.10%
September 30, 2024
Summary
- As of February 7, 2025, CCRN quarterly EBITDA is $8.44 million, with the most recent change of +$22.71 million (+159.10%) on September 30, 2024.
- Over the past year, CCRN quarterly EBITDA has dropped by -$9.59 million (-53.20%).
- CCRN quarterly EBITDA is now -92.42% below its all-time high of $111.35 million, reached on March 31, 2001.
Performance
CCRN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$20.98 M
-$16.27 M-43.68%
September 30, 2024
Summary
- As of February 7, 2025, CCRN TTM EBITDA is $20.98 million, with the most recent change of -$16.27 million (-43.68%) on September 30, 2024.
- Over the past year, CCRN TTM EBITDA has dropped by -$108.35 million (-83.78%).
- CCRN TTM EBITDA is now -93.21% below its all-time high of $309.10 million, reached on September 30, 2022.
Performance
CCRN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CCRN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -54.4% | -53.2% | -83.8% |
| 3 y3 years | +3902.9% | -82.7% | -91.2% |
| 5 y5 years | +10000.0% | +69.9% | +534.4% |
CCRN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -54.4% | at low | -91.0% | +159.1% | -93.2% | at low |
| 5 y | 5-year | -54.4% | +2777.7% | -91.0% | +159.1% | -93.2% | +534.4% |
| alltime | all time | -54.4% | +168.4% | -92.4% | +103.7% | -93.2% | +110.3% |
Cross Country Healthcare EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $8.44 M(-159.1%) | $20.98 M(-43.7%) |
| Jun 2024 | - | -$14.28 M(-262.3%) | $37.25 M(-58.3%) |
| Mar 2024 | - | $8.79 M(-51.2%) | $89.42 M(-30.9%) |
| Dec 2023 | $129.34 M(-54.3%) | $18.03 M(-27.0%) | $129.34 M(-21.3%) |
| Sep 2023 | - | $24.71 M(-34.8%) | $164.34 M(-15.7%) |
| Jun 2023 | - | $37.89 M(-22.2%) | $195.04 M(-18.3%) |
| Mar 2023 | - | $48.71 M(-8.1%) | $238.65 M(-15.8%) |
| Dec 2022 | $283.29 M(+89.0%) | $53.03 M(-4.3%) | $283.29 M(-8.3%) |
| Sep 2022 | - | $55.42 M(-32.0%) | $309.10 M(+9.2%) |
| Jun 2022 | - | $81.49 M(-12.7%) | $283.19 M(+28.7%) |
| Mar 2022 | - | $93.36 M(+18.4%) | $220.00 M(+46.7%) |
| Dec 2021 | $149.93 M(+4540.2%) | $78.84 M(+167.2%) | $149.93 M(+90.7%) |
| Sep 2021 | - | $29.50 M(+61.2%) | $78.63 M(+51.2%) |
| Jun 2021 | - | $18.30 M(-21.4%) | $52.00 M(+117.2%) |
| Mar 2021 | - | $23.28 M(+209.0%) | $23.94 M(+641.0%) |
| Dec 2020 | $3.23 M(-166.9%) | $7.54 M(+162.0%) | $3.23 M(+388.1%) |
| Sep 2020 | - | $2.88 M(-129.5%) | $662.00 K(-229.3%) |
| Jun 2020 | - | -$9.75 M(-479.1%) | -$512.00 K(-77.5%) |
| Mar 2020 | - | $2.57 M(-48.2%) | -$2.27 M(-52.9%) |
| Dec 2019 | -$4.83 M(+534.7%) | $4.97 M(+191.8%) | -$4.83 M(-84.4%) |
| Sep 2019 | - | $1.70 M(-114.8%) | -$30.89 M(+14.7%) |
| Jun 2019 | - | -$11.52 M(<-9900.0%) | -$26.92 M(+236.5%) |
| Mar 2019 | - | $18.00 K(-100.1%) | -$8.00 M(+951.4%) |
| Dec 2018 | -$761.00 K(-104.1%) | -$21.09 M(-471.9%) | -$761.00 K(-104.5%) |
| Sep 2018 | - | $5.67 M(-23.4%) | $16.90 M(-24.9%) |
| Jun 2018 | - | $7.40 M(+2.0%) | $22.50 M(-5.8%) |
| Mar 2018 | - | $7.26 M(-311.3%) | $23.89 M(+27.8%) |
| Dec 2017 | $18.69 M(-5.8%) | -$3.44 M(-130.5%) | $18.69 M(-1.5%) |
| Sep 2017 | - | $11.27 M(+28.2%) | $18.96 M(-27.9%) |
| Jun 2017 | - | $8.79 M(+327.3%) | $26.31 M(-1330.0%) |
| Mar 2017 | - | $2.06 M(-165.1%) | -$2.14 M(-110.8%) |
| Dec 2016 | $19.83 M(+4.2%) | -$3.16 M(-117.0%) | $19.83 M(-8.3%) |
| Sep 2016 | - | $18.62 M(-194.7%) | $21.63 M(+139.9%) |
| Jun 2016 | - | -$19.66 M(-181.8%) | $9.02 M(-74.5%) |
| Mar 2016 | - | $24.03 M(-1857.9%) | $35.30 M(+85.4%) |
| Dec 2015 | $19.04 M(-196.5%) | -$1.37 M(-122.8%) | $19.04 M(+345.0%) |
| Sep 2015 | - | $6.01 M(-9.4%) | $4.28 M(-182.3%) |
| Jun 2015 | - | $6.63 M(-14.6%) | -$5.20 M(-57.1%) |
| Mar 2015 | - | $7.77 M(-148.2%) | -$12.11 M(-38.6%) |
| Dec 2014 | -$19.72 M(+555.0%) | -$16.13 M(+365.1%) | -$19.72 M(+115.7%) |
| Sep 2014 | - | -$3.47 M(+1116.5%) | -$9.14 M(+182.7%) |
| Jun 2014 | - | -$285.00 K(-277.0%) | -$3.23 M(+12.6%) |
| Mar 2014 | - | $161.00 K(-102.9%) | -$2.87 M(-4.6%) |
| Dec 2013 | -$3.01 M(-80.7%) | -$5.55 M(-327.4%) | -$3.01 M(-179.5%) |
| Sep 2013 | - | $2.44 M(+3029.5%) | $3.79 M(+87.2%) |
| Jun 2013 | - | $78.00 K(+254.5%) | $2.02 M(-111.9%) |
| Mar 2013 | - | $22.00 K(-98.2%) | -$16.99 M(+8.9%) |
| Dec 2012 | -$15.61 M | $1.25 M(+83.9%) | -$15.61 M(-3.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | $677.00 K(-103.6%) | -$16.13 M(+60.4%) |
| Jun 2012 | - | -$18.93 M(-1445.8%) | -$10.06 M(-170.7%) |
| Mar 2012 | - | $1.41 M(+95.9%) | $14.23 M(-15.1%) |
| Dec 2011 | $16.76 M(+104.6%) | $718.20 K(-89.4%) | $16.76 M(+161.2%) |
| Sep 2011 | - | $6.75 M(+26.1%) | $6.41 M(+20.4%) |
| Jun 2011 | - | $5.36 M(+36.2%) | $5.33 M(-19.1%) |
| Mar 2011 | - | $3.93 M(-140.9%) | $6.58 M(-19.6%) |
| Dec 2010 | $8.19 M(-73.3%) | -$9.62 M(-269.9%) | $8.19 M(-64.6%) |
| Sep 2010 | - | $5.67 M(-14.3%) | $23.16 M(-5.3%) |
| Jun 2010 | - | $6.61 M(+19.4%) | $24.47 M(-4.4%) |
| Mar 2010 | - | $5.54 M(+3.5%) | $25.59 M(-16.4%) |
| Dec 2009 | $30.62 M(-116.2%) | $5.35 M(-23.3%) | $30.62 M(-115.0%) |
| Sep 2009 | - | $6.97 M(-9.8%) | -$203.67 M(+3.4%) |
| Jun 2009 | - | $7.74 M(-26.8%) | -$196.89 M(+3.0%) |
| Mar 2009 | - | $10.56 M(-104.6%) | -$191.11 M(+1.0%) |
| Dec 2008 | -$189.14 M(-475.4%) | -$228.95 M(-1763.9%) | -$189.14 M(-447.3%) |
| Sep 2008 | - | $13.76 M(+1.8%) | $54.46 M(-1.1%) |
| Jun 2008 | - | $13.52 M(+7.9%) | $55.07 M(+4.4%) |
| Mar 2008 | - | $12.53 M(-14.5%) | $52.73 M(+4.7%) |
| Dec 2007 | $50.38 M(+43.1%) | $14.66 M(+2.0%) | $50.38 M(+0.5%) |
| Sep 2007 | - | $14.37 M(+28.6%) | $50.12 M(+32.2%) |
| Jun 2007 | - | $11.18 M(+9.9%) | $37.93 M(+5.3%) |
| Mar 2007 | - | $10.17 M(-29.3%) | $36.02 M(+2.4%) |
| Dec 2006 | $35.19 M(-5.6%) | $14.40 M(+561.7%) | $35.19 M(+4.6%) |
| Sep 2006 | - | $2.18 M(-76.5%) | $33.66 M(-20.9%) |
| Jun 2006 | - | $9.28 M(-0.7%) | $42.56 M(+12.1%) |
| Mar 2006 | - | $9.34 M(-27.3%) | $37.97 M(+1.9%) |
| Dec 2005 | $37.28 M(-16.9%) | $12.86 M(+16.1%) | $37.28 M(+2.3%) |
| Sep 2005 | - | $11.08 M(+136.4%) | $36.44 M(+0.6%) |
| Jun 2005 | - | $4.69 M(-45.8%) | $36.22 M(-15.4%) |
| Mar 2005 | - | $8.65 M(-28.0%) | $42.80 M(-5.6%) |
| Dec 2004 | $44.88 M(-20.2%) | $12.02 M(+10.6%) | $45.33 M(-0.5%) |
| Sep 2004 | - | $10.86 M(-3.6%) | $45.53 M(-8.1%) |
| Jun 2004 | - | $11.27 M(+0.8%) | $49.57 M(-6.3%) |
| Mar 2004 | - | $11.18 M(-8.5%) | $52.89 M(-5.9%) |
| Dec 2003 | $56.21 M(-12.5%) | $12.22 M(-17.9%) | $56.22 M(-7.0%) |
| Sep 2003 | - | $14.89 M(+2.0%) | $60.46 M(-3.2%) |
| Jun 2003 | - | $14.60 M(+0.6%) | $62.46 M(-2.6%) |
| Mar 2003 | - | $14.51 M(-11.8%) | $64.14 M(-0.2%) |
| Dec 2002 | $64.24 M(+11.9%) | $16.46 M(-2.6%) | $64.27 M(-2.6%) |
| Sep 2002 | - | $16.89 M(+3.8%) | $65.98 M(+1.6%) |
| Jun 2002 | - | $16.28 M(+11.1%) | $64.93 M(-59.4%) |
| Mar 2002 | - | $14.65 M(-19.4%) | $160.00 M(-37.7%) |
| Dec 2001 | $57.42 M(+31.0%) | $18.16 M(+14.7%) | $256.71 M(+7.6%) |
| Sep 2001 | - | $15.84 M(-85.8%) | $238.55 M(+7.1%) |
| Jun 2001 | - | $111.35 M(0.0%) | $222.71 M(+100.0%) |
| Mar 2001 | - | $111.35 M | $111.35 M |
| Dec 2000 | $43.85 M(-135.0%) | - | - |
| Dec 1999 | -$125.28 M | - | - |
FAQ
- What is Cross Country Healthcare annual EBITDA?
- What is the all time high annual EBITDA for Cross Country Healthcare?
- What is Cross Country Healthcare annual EBITDA year-on-year change?
- What is Cross Country Healthcare quarterly EBITDA?
- What is the all time high quarterly EBITDA for Cross Country Healthcare?
- What is Cross Country Healthcare quarterly EBITDA year-on-year change?
- What is Cross Country Healthcare TTM EBITDA?
- What is the all time high TTM EBITDA for Cross Country Healthcare?
- What is Cross Country Healthcare TTM EBITDA year-on-year change?
What is Cross Country Healthcare annual EBITDA?
The current annual EBITDA of CCRN is $129.34 M
What is the all time high annual EBITDA for Cross Country Healthcare?
Cross Country Healthcare all-time high annual EBITDA is $283.29 M
What is Cross Country Healthcare annual EBITDA year-on-year change?
Over the past year, CCRN annual EBITDA has changed by -$153.96 M (-54.35%)
What is Cross Country Healthcare quarterly EBITDA?
The current quarterly EBITDA of CCRN is $8.44 M
What is the all time high quarterly EBITDA for Cross Country Healthcare?
Cross Country Healthcare all-time high quarterly EBITDA is $111.35 M
What is Cross Country Healthcare quarterly EBITDA year-on-year change?
Over the past year, CCRN quarterly EBITDA has changed by -$9.59 M (-53.20%)
What is Cross Country Healthcare TTM EBITDA?
The current TTM EBITDA of CCRN is $20.98 M
What is the all time high TTM EBITDA for Cross Country Healthcare?
Cross Country Healthcare all-time high TTM EBITDA is $309.10 M
What is Cross Country Healthcare TTM EBITDA year-on-year change?
Over the past year, CCRN TTM EBITDA has changed by -$108.35 M (-83.78%)